Improving bone healing in older adults with targeted medicine
Modulated release of anti-senescence drugs to stimulate aged bone repair
This research explores a new way to help older adults heal broken bones faster by delivering special medicines directly to the injury site.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11017627 on NIH RePORTER |
What this research studies
As we age, our bodies can have a harder time healing broken bones, partly because of how our immune system responds. This project is developing a clever way to deliver special medicines directly to a bone injury. These medicines target 'senescent' cells, which are older cells that can cause inflammation and slow down healing. By using a temporary barrier, we can control when and how these medicines are released to help immune cells called macrophages switch from causing inflammation to promoting repair, aiming to improve bone healing in older adults.
Who could benefit from this research
Good fit: This research is most relevant for older adults who experience bone fractures or have conditions that impair bone healing due to aging.
Not a fit: Patients whose bone healing issues are not related to aging or senescent cells may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this approach could lead to new treatments that significantly speed up and improve bone repair for older individuals.
How similar studies have performed: While systemic anti-senescence drugs have shown promise in animal models for bone density, this local delivery method using a transient barrier layer is a novel approach.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Kuhn, Liisa Tiina — University of Connecticut Sch of Med/dnt
- Study coordinator: Kuhn, Liisa Tiina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.